| . | First implant (n = 903) . | Additional HV lead(s) (n = 60) . | Additional P/S lead (n = 13) . | Lead extraction (n = 21) . | P value . |
|---|---|---|---|---|---|
| Sensing of artefacts | 42 (4.7%) | 4 (6.7%) | 1 (7.7%) | 4 (19.0%) | 0.11 |
| HV lead defect | 63 (7.0%) | 4 (6.7%) | 1 (7.7%) | 3 (14.3%) | 0.64 |
| Unsuccessful HV delivery | 3 (0.3%) | 0 | 0 | 0 | 0.96 |
| Symptomatic thrombosis of subclavian vein | 8 (0.9%) | 2 (3.3%) | 0 | 0 | 0.29 |
| Combined endpoint | 78 (8.6%) | 6 (10.0%) | 1 (7.7%) | 4 (19.0%) | 0.42 |
| Death | 142 (15.7%) | 6 (10.0%) | 2 (15.4%) | 2 (9.5%) | 0.54 |
| . | First implant (n = 903) . | Additional HV lead(s) (n = 60) . | Additional P/S lead (n = 13) . | Lead extraction (n = 21) . | P value . |
|---|---|---|---|---|---|
| Sensing of artefacts | 42 (4.7%) | 4 (6.7%) | 1 (7.7%) | 4 (19.0%) | 0.11 |
| HV lead defect | 63 (7.0%) | 4 (6.7%) | 1 (7.7%) | 3 (14.3%) | 0.64 |
| Unsuccessful HV delivery | 3 (0.3%) | 0 | 0 | 0 | 0.96 |
| Symptomatic thrombosis of subclavian vein | 8 (0.9%) | 2 (3.3%) | 0 | 0 | 0.29 |
| Combined endpoint | 78 (8.6%) | 6 (10.0%) | 1 (7.7%) | 4 (19.0%) | 0.42 |
| Death | 142 (15.7%) | 6 (10.0%) | 2 (15.4%) | 2 (9.5%) | 0.54 |
HV, high voltage; P/S, pace/sense.
| . | First implant (n = 903) . | Additional HV lead(s) (n = 60) . | Additional P/S lead (n = 13) . | Lead extraction (n = 21) . | P value . |
|---|---|---|---|---|---|
| Sensing of artefacts | 42 (4.7%) | 4 (6.7%) | 1 (7.7%) | 4 (19.0%) | 0.11 |
| HV lead defect | 63 (7.0%) | 4 (6.7%) | 1 (7.7%) | 3 (14.3%) | 0.64 |
| Unsuccessful HV delivery | 3 (0.3%) | 0 | 0 | 0 | 0.96 |
| Symptomatic thrombosis of subclavian vein | 8 (0.9%) | 2 (3.3%) | 0 | 0 | 0.29 |
| Combined endpoint | 78 (8.6%) | 6 (10.0%) | 1 (7.7%) | 4 (19.0%) | 0.42 |
| Death | 142 (15.7%) | 6 (10.0%) | 2 (15.4%) | 2 (9.5%) | 0.54 |
| . | First implant (n = 903) . | Additional HV lead(s) (n = 60) . | Additional P/S lead (n = 13) . | Lead extraction (n = 21) . | P value . |
|---|---|---|---|---|---|
| Sensing of artefacts | 42 (4.7%) | 4 (6.7%) | 1 (7.7%) | 4 (19.0%) | 0.11 |
| HV lead defect | 63 (7.0%) | 4 (6.7%) | 1 (7.7%) | 3 (14.3%) | 0.64 |
| Unsuccessful HV delivery | 3 (0.3%) | 0 | 0 | 0 | 0.96 |
| Symptomatic thrombosis of subclavian vein | 8 (0.9%) | 2 (3.3%) | 0 | 0 | 0.29 |
| Combined endpoint | 78 (8.6%) | 6 (10.0%) | 1 (7.7%) | 4 (19.0%) | 0.42 |
| Death | 142 (15.7%) | 6 (10.0%) | 2 (15.4%) | 2 (9.5%) | 0.54 |
HV, high voltage; P/S, pace/sense.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
